<DOC>
	<DOCNO>NCT00162708</DOCNO>
	<brief_summary>Altered fractionate radiotherapy concomitant radio-chemotherapy show two possibility improve efficacy radiotherapy locally advanced head neck carcinoma . In multicentric study , test hypothesis accelerate radiotherapy could deliver concomitantly conventional high dos CDDP-5FU , aim improve local control distant metastasis compare accelerated radiotherapy .</brief_summary>
	<brief_title>Very Intense Radiotherapy-Chemotherapy Regimen Advanced HNSCC</brief_title>
	<detailed_description>Patients palpable N2b-c N3 HNSCC strictly unresectable randomize receive either accelerate RT-CT deliver primary tumor 62-64 Gy / 5 week 31-32 fraction 2 Gy BID accelerate RT deliver 62-64 Gy 31-32 fraction 2 Gy BID 22-23 day . In accelerated RT-CT arm , 3 cycle CDDP 100 mg/m2 deliver day 1 , 16 , 32 2 cycle 5 Fu 1000 mg/m2 day 1 5 31 35 . One month completion concomitant RT-CT , 2 additional cycle CDDP-5FU give patient respond ( &gt; 50 % ) initial course RT-CT . The end point event free survival survival .</detailed_description>
	<mesh_term>Mouth Neoplasms</mesh_term>
	<mesh_term>Laryngeal Neoplasms</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<criteria>palpable N2bc N3 ( UICC 1997 ) squamous cell carcinoma head neck ( oropharynx , oral cavity , hypopharynx larynx ) primary tumor / nodal extension strictly inoperable due extension disease performance status 0 2 ( WHO score system ) renal/liver/cardiac function blood count compatible use CDDP 5FU sign inform consent distant metastasis previous history cancer previous radiotherapy chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Head neck squamous cell carcinoma</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>